Skip to content

Addiction: all studies

Page 410 of 857: studies 4,091 to 4,100 of 8,563, newest first. Back to the addiction overview

Research

Region- and time- specific effects of ketamine on cerebral blood flow: a randomized controlled trial.

Neuropsychopharmacology May 25, 2023 Matti Gärtner, Anne Weigand, Marvin Sören Meiering et al.

There is intriguing evidence suggesting that ketamine might have distinct acute and delayed neurofunctional effects, as its acute administration transiently induces schizophrenia-like symptoms, while antidepressant effects slowly emerge and are most pronounced 24 h after administration. Studies attempting to characterize ketamine's mechanism of action by using blood oxygen level dependent...

Self-regulation of the posterior-frontal brain activity with real-time fMRI neurofeedback to influence conscious perception

Research Square May 24, 2023 Sunjung Kim, Josué Luiz Dalboni da Rocha, Niels Birbaumer et al. preprint

Abstract The Global Neuronal Workspace (GNW) hypothesis states that the visual percept is available to conscious awareness only if recurrent long-distance interactions among distributed brain regions activate neural circuitry extending from posterior regions to prefrontal regions above a certain excitation threshold. To directly test this hypothesis, we trained human participants to increase...

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.

Translational Psychiatry May 23, 2023 Severin B Vogt, Laura Ley, Livio Erne et al. 85 citations

N,N-dimethyltryptamine (DMT) is distinct among classic serotonergic psychedelics because of its short-lasting effects when administered intravenously. Despite growing interest in the experimental and therapeutic use of intravenous DMT, data are lacking on its clinical pharmacology. We conducted a double-blind, randomized, placebo-controlled crossover trial in 27 healthy participants to test...

DOI: 10.1038/s41398-023-02477-4 (opens in new tab) Full text (opens in new tab) Psychedelic medicine DMT Research Clinical trials Intravenous drug administration +1

Acute psilocybin increased cortical activities in rats

Frontiers in Neuroscience May 23, 2023 Junhong Liu, Yuanyuan Wang, Ke Xia et al. 17 citations Retracted

Psilocybin, a naturally occurring hallucinogenic component of magic mushrooms, has significant psychoactive effects in both humans and rodents. But the underlying mechanisms are not fully understood. Blood-oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) is a useful tool in many preclinical and clinical trials to investigate psilocybin-induced changes of brain...

Mindfulness mechanisms in alcohol use: Comparing top-down and bottom-up processes.

Psychology of Addictive Behaviors May 18, 2023 Carillon J. Skrzynski, Angela D Bryan, Kent E. Hutchison

Objective: This study compared two mechanisms by which mindfulness may reduce hazardous drinking: effortful control and craving, "top-down" and "bottom-up" processes, respectively. These relationships were compared in a secondary analysis of a randomized controlled trial of mindfulness-based relapse prevention (MBRP) versus relapse prevention (RP) treatments to explore if they differed based on...

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system

Frontiers in Psychiatry May 18, 2023 Tigran Makunts, Diane Dahill, Lisa Jerome et al. 6 citations

3,4-Methylenedioxymethamphetamine (MDMA) is currently being investigated as an adjunctive treatment to therapy for posttraumatic stress and other anxiety related disorders in clinical trials. Within the next few years MDMA-assisted therapy is projected for approval by regulatory authorities. MDMA's primary mechanism of action includes modulation of monoamine signaling by increasing release and...

DOI: 10.3389/fpsyt.2023.1149766 (opens in new tab) MDMA Concomitant Adverse effect Anesthesia +1

Patients with Disorders of Consciousness: Are They Nonconscious, Unconscious, or Subconscious? Expanding the Discussion.

Brain Sciences May 17, 2023 Andrew A Fingelkurts, Alexander A Fingelkurts 9 citations

Unprecedented advancements in the diagnosis and treatment of patients with disorders of consciousness (DoC) have given rise to ethical questions about how to recognize and respect autonomy and a sense of agency of the personhood when those capacities are themselves disordered, as they typically are in patients with DoC. At the intersection of these questions rests the distinction between...

Between life and death: the brain twilight zones

Frontiers in Neuroscience May 15, 2023 Stéphane Charpier 14 citations

Clinically, and legally, death is considered a well-defined state of the organism characterized, at least, by a complete and irreversible cessation of brain activities and functions. According to this pragmatic approach, the moment of death is implicitly represented by a discrete event from which all cerebral processes abruptly cease. However, a growing body of experimental and clinical...

Ketamine reduces electrophysiological network activity in cortical neuron cultures already at sub-micromolar concentrations - Impact on TrkB-ERK1/2 signaling.

Neuropharmacology May 15, 2023 A Ahtiainen, Iina Annala, Marko Rosenholm et al.

The dissociative anesthetic ketamine regulates cortical activity in a dose-dependent manner. Subanesthetic-dose ketamine has paradoxical excitatory effects which is proposed to facilitate brain-derived neurotrophic factor (BDNF) (a ligand of tropomyosin receptor kinase B, TrkB) signaling, and activation of extracellular signal-regulated kinase 1/2 (ERK1/2). Previous data suggests that ketamine,...

DOI: 10.1016/j.neuropharm.2023.109481 (opens in new tab) Full text (opens in new tab) Ketamine Cortical neuron culture Extracellular electrophysiology Microelectrode array +2